Ads
related to: Stelara- Common Side Effect Info
Get Safety Info & Talk To A Doctor
Before Starting This Treatment.
- Sign Up For Updates
Stay Informed About This Treatment
Option By Signing Up For Updates.
- Find Savings Resources
Access Financial Information And
Other Patient Support Resources.
- Unique Patient Support
Find Patient Support As Unique As
You And Access A Dedicated Nurse.
- View Clinical Results
Discover Treatment Effectiveness &
Learn About Patients' Experiences.
- View An Injection Video
Some Patients May Use Prefilled
Syringes. Find Self-Injection Info.
- Common Side Effect Info
Search results
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 2 hours agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...
Stelara biosimilar from Alvotech, Teva approved by FDA
BioPharma Dive via Yahoo Finance· 15 hours agoThe FDA cleared Selarsdi for treatment of moderate to severe plaque psoriasis and active psoriatic...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 1 day ago(NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara ...
FDA approves Alvotech biosimilar of J&J top-selling drug Stelara (NYSE:TEVA)
Seeking Alpha· 1 day agoThe FDA has approved Alvotech’s biosimilar of Johnson & Johnson’s (JNJ) Stelara, with Teva hoping to...
Bellwether Health Giant J&J Skids As Psoriasis Blockbuster Drags Top Line
Investor's Business Daily· 1 day agoJohnson & Johnson stock skidded early Tuesday after light sales of blockbuster psoriasis treatment ...
J&J first-quarter revenue misses as Stelara sales disappoint By Reuters
Investing.com· 2 days agoStelara sales were flat at $2.45 billion in the first quarter and came in below expectations of $2.6...
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment
Market Watch· 1 day agoAlvotech and Teva Pharmaceuticals said the Food and Drug Administration approved the Selarsdi injection for subcutaneous use as a biosimilar to Stelara for the treatment of ...
J&J's medical device sales fall short, cancer drugs seen growing
Reuters via Yahoo News· 2 days ago(Reuters) -Johnson & Johnson's first-quarter revenue missed Wall Street estimates for medical...
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
Zacks via Yahoo Finance· 12 hours agoThe cancer drug is expected to bring in sales of more than $11 billion this year, according to...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 1 day agoInnovative Medicines sales beat the Zacks Consensus Estimate of $13.46 billion as well as our model...
Ads
related to: Stelara